Sanofi’s mixed fortunes in MS drug trials has market focus on win
By Ludwig Burger (Reuters) -Sanofi’s most advanced multiple sclerosis drug candidate has missed the main goal of two late-stage trials...
Read moreBy Ludwig Burger (Reuters) -Sanofi’s most advanced multiple sclerosis drug candidate has missed the main goal of two late-stage trials...
Read more(This Aug. 31 story has been corrected to clarify Silicon Valley Bank exited its China join venture, not that it...
Read moreInvesting.com – Taiwan stocks were higher after the close on Monday, as gains in the Construction, Transport and Other sectors...
Read moreInvesting.com – Australia stocks were higher after the close on Monday, as gains in the Financials, Energy and Industrials sectors...
Read moreInvesting.com – Japan stocks were higher after the close on Monday, as gains in the Shipbuilding, Power and Manufacturing sectors...
Read moreBy Kane Wu and Gnaneshwar Rajan (Reuters) -A consortium led by Blackstone (NYSE:BX) is nearing a deal to acquire Australian...
Read moreBy Munsif Vengattil and Aditya Kalra NEW DELHI (Reuters) – Apple (NASDAQ:AAPL)’s partnership with India’s second-biggest telecoms firm will give...
Read moreSHANGHAI (Reuters) – China’s State Administration of Market Regulation (SAMR) said on Friday that Alibaba (NYSE:BABA) Group had completed three...
Read moreBy Dawn Chmielewski and Lisa Richwine (Reuters) -Walt Disney and satellite TV provider DirecTV failed to reach a new distribution...
Read more(Reuters) – Shares of casino operator Star Entertainment are suspended from quotation for not lodging its finanical results by the...
Read more